Actively Recruiting

Phase Not Applicable
Age: 21Years - 80Years
All Genders
Healthy Volunteers
NCT06506058

Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease

Led by University of Minnesota · Updated on 2026-03-19

75

Participants Needed

1

Research Sites

197 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Currently, there is a lack of comprehensive knowledge about the role of vestibulospinal drive and cortical activity during self-initiated movement transitions in older adults and people with PD (both with and without FOG). This set of experiments has two primary purposes: to (1) understand the pathological neurophysiology underlying freezing of gait (FOG) during movement transitions and FOG-inducing movements and (2) identify neurological biomarkers associated with FOG and FOG-inducing movements. To achieve this, the investigators will assess vestibular activity using the noninvasive neuromodulation technique of electrical vestibular stimulation (EVS, Experiments 1 and 2) and assess cortical activity by recording via electroencephalography (EEG, Experiments 3 and 4, no stimulation included). These experiments will investigate the vestibular (EVS Experiments) and cortical (EEG experiments) contributions to movement transitions during standing, walking, turning, and changing movement rates. Upon completion of this project, the investigators expect to provide a new understanding of key neural systems (vestibular and cortical) involved in the pathogenesis of movement impairment and freezing episodes during movement transitions including gait initiation, turning, and changing movement rates, in people with PD. An increased understanding of the temporal dynamics of systems involved in FOG and FOG-inducing movements could later guide the development and delivery of novel interventions (e.g. closed-loop deep brain stimulation \[DBS\] or non-invasive brain stimulation) to decrease the incidence and severity of FOG episodes, reducing fall risk and morbidity.

CONDITIONS

Official Title

Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease

Who Can Participate

Age: 21Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants with Parkinson's disease (with and without Freezing of Gait) diagnosed with idiopathic PD
  • Aged 40 to 80 years
  • Able to walk independently without assistive devices for 50 meters
  • Healthy older adults aged 40 to 80 years, matched by age and sex to PD group
  • Healthy older adults able to walk independently without assistive devices
  • Healthy young adults aged 21 to 44 years, sex-matched to PD group
  • Healthy young adults able to walk independently without assistive devices
  • Healthy older adults must have normal capacity to perform complex daily activities independently
Not Eligible

You will not qualify if you...

  • Any musculoskeletal disorder affecting standing or walking
  • History of musculoskeletal disorders significantly affecting lower limb movement
  • Uncorrected visual impairments affecting participation
  • History of visual or vestibular conditions affecting participation
  • Diagnosis of dementia with Lewy bodies, multiple system atrophy, Alzheimer's, or other neurodegenerative disorders besides Parkinson's
  • History of seizures, epilepsy, stroke, multiple sclerosis, traumatic brain injury, or other significant neurological disorders
  • History of neck or back muscular conditions including whiplash
  • History of surgery on blood vessels, brain, or heart
  • Unexplained recurring headaches or concussion within the last six months
  • Moderate to severe hearing impairment
  • Pregnant individuals
  • Reduced capacity to consent as assessed by standardized tools
  • For EVS experiments: history of motion sickness, recent intense exercise or alcohol, recent migraine, intracranial metallic or magnetic devices, pacemaker or implanted devices, implanted deep brain stimulator or neurosurgeries for PD, medications causing dizziness
  • For control participants: presence of parkinsonism or cognitive impairment, active central nervous system, systemic or psychiatric conditions, or use of psychoactive medications affecting cognition or motor function

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Minnesota, Movement Disorders Lab

Minneapolis, Minnesota, United States, 55455

Actively Recruiting

Loading map...

Research Team

M

Madison Aasen, MS

CONTACT

S

Sommer Amundsen-Huffmaster, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here